⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18274725 | 0.72 | — | — | |
| SCHEMBL10337132 | 0.69 | — | — | |
| SCHEMBL18274714 | 0.66 | — | — | |
| SCHEMBL8412790 | 0.64 | — | — | |
| SCHEMBL7135166 | 0.64 | — | — | |
| SCHEMBL9517574 | 0.62 | — | — | |
| SCHEMBL18274686 | 0.61 | — | — | |
| SCHEMBL10660110 | 0.59 | CYP3A4 (0.33) | — | |
| SCHEMBL4879848 | 0.58 | ADRA1D (0.35) | — | |
| SCHEMBL10809908 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0377739-A4 | METHOD OF OBTAINING N-ALLYL-2-PYRIDINALDOXIME BROMIDE | — | 1990-12-05 | — | — | EP | disclosed |
| EP-0377739-A1 | METHOD OF OBTAINING N-ALLYL-2-PYRIDINALDOXIME BROMIDE | KIEVSKY NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII I TOXIKOLOGII (SU) | 1990-07-18 | — | — | EP | disclosed |
| EP-0377739-A1 | METHOD OF OBTAINING N-ALLYL-2-PYRIDINALDOXIME BROMIDE | KIEVSKY NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII I TOXIKOLOGII (SU) | 1990-07-18 | — | — | EP | disclosed |
| EP-0364584-A1 | ANTIDOTE FOR ORGANIC PHOSPHORUS COMPOUND POISONING | KIEVSKY NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII I TOXIKOLOGII (SU) | 1990-04-25 | — | — | EP | disclosed |
| WO-1989011474-A1 | METHOD OF OBTAINING N-ALLYL-2-PYRIDINALDOXIME BROMIDE | KIEVSKY NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLO (SU) | 1989-11-30 | — | — | WO | disclosed |